Literature DB >> 24621582

Allele frequency of a 24 bp duplication in exon 10 of the CHIT1 gene in the general Korean population and in Korean patients with Gaucher disease.

Kyu Ha Woo1, Beom Hee Lee2, Sun Hee Heo1, Jae-Min Kim3, Gu-Hwan Kim3, Yoo-Mi Kim2, Ja Hye Kim2, In-Hee Choi3, Song Hyun Yang4, Han-Wook Yoo2.   

Abstract

Plasma chitotriosidase activity is used for diagnosis and monitoring of Gaucher disease. However, homozygous duplication of a 24 bp region in exon 10 of the chitotriosidase gene (CHIT1) abolishes enzyme activity, limiting its use as a biomarker in Gaucher disease. This study investigates the allele frequency of the 24 bp duplication, in both the general Korean population and in patients with Gaucher disease. Fifteen Korean patients with Gaucher disease and 231 Korean normal individuals were enrolled. Genotyping was performed to identify the 24 bp duplication in exon 10 of CHIT1 using DNA extracted from peripheral leukocytes or dried blood spots. Two patients with Gaucher disease (13.3%) had normal plasma chitotriosidase activity, and carried a homozygous 24 bp duplication of exon 10 of the CHIT1 gene. Nine patients were heterozygote carriers (60.0%). Of the normal 231 Korean individuals, heterozygous duplication was detected in 109 individuals (47.2%) and homozygous duplication in 75 (32.5%). The allele frequency was 56.1% (95% confidence interval, 49.4-62.7%). The frequency of the 24 bp duplication was remarkably high in both Korean patients with Gaucher disease and in the normal population, limiting the efficacy of chitotriosidase as a biomarker in Gaucher disease in Korea. New biomarkers are required that consider the genetic characteristics of different populations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24621582     DOI: 10.1038/jhg.2014.16

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  22 in total

1.  Plasma chitotriosidase activity and malaria.

Authors:  Y-H Chien; J-H Chen; W-L Hwu
Journal:  Clin Chim Acta       Date:  2005-03       Impact factor: 3.786

2.  Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity.

Authors:  Marco van Eijk; Cindy P A A van Roomen; G Herma Renkema; Anton P Bussink; Laura Andrews; Edward F C Blommaart; Alan Sugar; Arthur J Verhoeven; Rolf G Boot; Johannes M F G Aerts
Journal:  Int Immunol       Date:  2005-10-07       Impact factor: 4.823

3.  Progressive mesenteric lymphadenopathy with protein-losing enteropathy; a devastating complication in Gaucher disease.

Authors:  Beom Hee Lee; Dae-Yeon Kim; Gu-Hwan Kim; Kyung-Ja Cho; Hye-Kyung Yoon; Han-Wook Yoo
Journal:  Mol Genet Metab       Date:  2011-12-16       Impact factor: 4.797

Review 4.  Chitotriosidase: the yin and yang.

Authors:  L Malaguarnera
Journal:  Cell Mol Life Sci       Date:  2006-12       Impact factor: 9.261

5.  Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy.

Authors:  Mario A Cabrera-Salazar; Erin O'Rourke; Nadene Henderson; Howard Wessel; John A Barranger
Journal:  Clin Chim Acta       Date:  2004-06       Impact factor: 3.786

6.  Neonatal administration of N-omega-nitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by D-amphetamine in postpubertal rats.

Authors:  Julio César Morales-Medina; Alejandro Mejorada; Alejandra Romero-Curiel; Patricia Aguilar-Alonso; Bertha Alicia León-Chávez; Citlalli Gamboa; Remi Quirion; Gonzalo Flores
Journal:  Neuropharmacology       Date:  2008-08-26       Impact factor: 5.250

7.  Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring.

Authors:  Marie E Grace; Manisha Balwani; Irina Nazarenko; Ainu Prakash-Cheng; Robert J Desnick
Journal:  Hum Mutat       Date:  2007-09       Impact factor: 4.878

8.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Authors:  C E Hollak; S van Weely; M H van Oers; J M Aerts
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Chitotriosidase activity in juvenile idiopathic arthritis.

Authors:  Jürgen K H Brunner; Sabine Scholl-Bürgi; David Hössinger; Petra Wondrak; Martina Prelog; Lothar-Bernd Zimmerhackl
Journal:  Rheumatol Int       Date:  2008-03-07       Impact factor: 2.631

10.  Assignment of the gene for acid beta-glucosidase to human chromosome 1.

Authors:  B Shafit-Zagardo; E A Devine; M Smith; F Arredondo-Vega; R J Desnick
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

View more
  4 in total

1.  Regulation and Role of Chitotriosidase during Lung Infection with Klebsiella pneumoniae.

Authors:  Lokesh Sharma; Alyssa K Amick; Swathy Vasudevan; Sei Won Lee; Chad R Marion; Wei Liu; Virginia Brady; Ashley Losier; Santos D Bermejo; Clemente J Britto; Chun Geun Lee; Jack A Elias; Charles S Dela Cruz
Journal:  J Immunol       Date:  2018-06-11       Impact factor: 5.422

2.  High prevalence of chitotriosidase deficiency in Peruvian Amerindians exposed to chitin-bearing food and enteroparasites.

Authors:  N Manno; S Sherratt; F Boaretto; F Mejìa Coico; C Espinoza Camus; C Jara Campos; S Musumeci; A Battisti; R J Quinnell; J Mostacero León; G Vazza; M L Mostacciuolo; M G Paoletti; F H Falcone
Journal:  Carbohydr Polym       Date:  2014-07-16       Impact factor: 9.381

3.  Chitotriosidase Activity and Gene Polymorphism in Iranian Patients with Gaucher Disease and Sibling Carriers.

Authors:  Hadi Mozafari; Mohammad Taghikhani; Shohreh Khatami; Mohammad Reza Alaei; Asad Vaisi-Raygani; Zohreh Rahimi
Journal:  Iran J Child Neurol       Date:  2016

Review 4.  Immunomodulatory Effects of Chitotriosidase Enzyme.

Authors:  Mohamed A Elmonem; Lambertus P van den Heuvel; Elena N Levtchenko
Journal:  Enzyme Res       Date:  2016-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.